Allarity Therapeutics, Inc. (ALLR) Net income 2020–2025
Allarity Therapeutics, Inc. (ALLR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$11.2MFY2025 · since FY2020: -$6.6M → -$11.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.2M | +54.2% |
| FY2024 | -$24.5M | -106.0% |
| FY2023 | -$11.9M | +25.9% |
| FY2022 | -$16.1M | +39.7% |
| FY2021 | -$26.6M | -302.7% |
| FY2020 | -$6.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALLR financial trends
ALLR RevenueALLR Net marginALLR Gross profitALLR Gross marginALLR Operating incomeALLR Operating marginALLR Operating cash flowALLR Free cash flowALLR Capital expendituresALLR Return on equityALLR Stock buybacksALLR Dividends paidALLR Total assetsALLR Total liabilitiesALLR Shareholders’ equityALLR overview →